E
Nuvectis Pharma, Inc. NVCT
$9.44 -$0.05-0.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -50.45% 6.21% -6.16% 37.01% -12.60%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -1.55% -8.16% -2.62% 6.23% 7.68%
Change in Net Operating Assets 347.80% 304.11% 109.84% -195.55% 3.19%
Cash from Operations -2.54% 20.40% 30.70% -13.19% -18.68%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 162.31% -12.74% -64.38% 438.18% -20.96%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -148.00% 9.09% 64.05% -1,056.25% 103.66%
Cash from Financing 162.80% -12.86% -64.40% 412.10% 30.44%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 244.03% 29.75% -498.82% 111.52% -15.43%
Weiss Ratings